PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression
Clinical trial NCT02213289 · COMPLETED
Trial details
- NCT number
- NCT02213289
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-20
- Primary completion
- 2020-02-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.